1. Home
  2. Browse
  3. Cardiology
  4. Dyslipidemia
  5. Treatment

Treatment

181 - 195 of 252 Results
Sort Results:
Article: whether intensive treatment of blood pressure or lipids is beneficial for type 2 diabetes patients April 2010
Article: limiting doses of simvastatin (Zocor, etc) to reduce myopathy April 2010
Article: The Ezetrol controversy and New Year's resolutions will spark new emphasis on treating lipids January 2010
Other: Niacin Titration Schedule January 2010
Commentary: Ezetimibe vs. Niacin for Atherosclerosis: The ARBITER 6-HALTS Study January 2010
Article: You'll hear more controversy about ezetimibe (Ezetrol) December 2009
Article: New Canadian dyslipidemia guidelines now recommend monitoring C-reactive protein in some patients November 2009
Article: whether Niaspan FCT has any advantages over the older formulation of Niaspan November 2009
Guideline: Canadian Guidelines for the Diagnosis and Treatment of Dyslipidemia and Prevention of Cardiovascular Disease in the Adult (CCS, 2009) November 2009
Article: questions about resolving statin myopathy October 2009
Guideline: Use and Safety of Statins (ACC/AHA/NHLBI, 2002) October 2009
Article: pharmacists are able to automatically switch between drugs in the same class to meet formulary requirements August 2009
Article: how to handle statin interactions August 2009
Chart: Pharmacist Prescriptive Authority August 2009
Chart: Sulfonylurea Dose Comparison August 2009